Acetylsalicylic acid (Aspirin, BAYE4465)
DrugAcetylsalicylic acid 500 mg orally, single dose, 1 tablet; in addition, 1 Placebo tablet of Acetylsalicylic acid, and 2 Placebo tablets of Ibuprofen
NCT Number: NCT01464983
The purpose of this study is to determine the efficacy and tolerability of 500 mg and 1000 mg Aspirin® (study medication) by comparing it to placebo (the control group without active substance) or 200 mg or 400 mg Ibuprofen (study medication) in treating the symptoms of episodic tension-type headache. The study is designed to develop a treatment method against episodic tension-type headache which will have more advantages for patients than the methods that are currently available.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 4
Reading, Berkshire, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Bilateral location. Pressing/tightening (non-pulsating). Mild or moderate intensity. Not aggravated by routine physical activity such as walking or climbing stairs.
Exclusion criteria
Acetylsalicylic acid 500 mg orally, single dose, 1 tablet; in addition, 1 Placebo tablet of Acetylsalicylic acid, and 2 Placebo tablets of Ibuprofen
Ibuprofen 200 mg orally, single dose, 1 tablet; in addition, 1 Placebo tablet of Ibuprofen, and 2 Placebo tablets of Acetylsalicylic Acid
2 Placebo tablets of Acetylsalicylic Acid, and 2 Placebo tablets of Ibuprofen, orally, single dose
Time frame: 2 hours post dose
Time frame: Until 4 hours post dose
Time frame: 2 and 24 hours post dose
Time frame: 24 hours post dose
Time frame: Up to 10 weeks after screening
Bayer
Industry
A Multicentre Randomised Parallel-groups Double-blind Double-dummy Single-dose Study to Compare Acetylsalicylic Acid 500 mg and 1,000 mg With Ibuprofen 200 mg and 400 mg and Placebo for Tolerability and Efficacy in the Treatment of Episodic Tension-type Headache
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06155669
Agnosia, Analgesia
Ankara, Çankaya, Turkey (Türkiye)
View Trial DetailsNCT04950413
Brain Diseases, Central Nervous System Diseases
Dokki, Egypt
View Trial DetailsNCT04736654
Brain Diseases, Central Nervous System Diseases
Ankara, None Selected, Turkey (Türkiye)
View Trial DetailsNCT04765501
Brain Diseases, Central Nervous System Diseases
Ankara, None Selected, Turkey (Türkiye)
View Trial Details